Related references
Note: Only part of the references are listed.Low testosterone bioavailability is related to prostate cancer diagnose in patients submitted to prostate biopsy
Eduard Garcia-Cruz et al.
WORLD JOURNAL OF UROLOGY (2012)
Preoperative Hypogonadism Is Not an Independent Predictor of High-Risk Disease in Patients Undergoing Radical Prostatectomy
Andrea Salonia et al.
CANCER (2011)
Circulating Estradiol, But Not Testosterone, Is a Significant Predictor of High-Grade Prostate Cancer in Patients Undergoing Radical Prostatectomy
Andrea Salonia et al.
CANCER (2011)
Performance of the Prostate Cancer Antigen 3 (PCA3) Gene and Prostate-Specific Antigen in Prescreened Men: Exploring the Value of PCA3 for a First-line Diagnostic Test
Monique J. Roobol et al.
EUROPEAN UROLOGY (2010)
Local prolactin is a target to prevent expansion of basal/stem cells in prostate tumors
Vincent Rouet et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Shifting the Paradigm of Testosterone and Prostate Cancer: The Saturation Model and the Limits of Androgen-Dependent Growth
Abraham Morgentaler et al.
EUROPEAN UROLOGY (2009)
Endogenous sex hormones and prostate cancer: A collaborative analysis of 18 prospective studies
Andrew W. Roddam et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2008)
Testosterone levels in benign prostatic hypertrophy and prostate cancer
Luigi Mearini et al.
UROLOGIA INTERNATIONALIS (2008)
Testosterone replacement therapy and prostate cancer
Abraham Morgentaler
UROLOGIC CLINICS OF NORTH AMERICA (2007)
Tissue and serum levels of principal androgens in benign prostatic hyperplasia and prostate cancer
Jiri Heracek et al.
STEROIDS (2007)
Prevalence of prostate cancer among hypogonadal men with prostate-specific antigen levels of 4.0 ng/mL or less
Abraham Morgentaler et al.
UROLOGY (2006)
The role of PSA in diagnosis of prostate cancer and its recurrence
DC Vergho et al.
PATHOLOGE (2005)
Immunohistochemical expression of Ki-67 antigen, Cox-2 and Bax/Bcl-2 in prostate cancer;: Prognostic value in biopsies and radical prostatectomy specimens
J Rubio et al.
EUROPEAN UROLOGY (2005)
Testosterone as a predictor of pathological stage in clinically localized prostate cancer
G Isom-Batz et al.
JOURNAL OF UROLOGY (2005)
Mechanisms of disease: polymorphisms of androgen regulatory genes in the development of prostate cancer
AS Singh et al.
NATURE CLINICAL PRACTICE UROLOGY (2005)
Detection of prostate cancer and predicting progression: Current and future diagnostic markers
JV Tricoli et al.
CLINICAL CANCER RESEARCH (2004)
Expression of the prolactin-inducible protein (PIP/GCDFP15) gene in benign epithelium and adenocarcinoma of the prostate
W Tian et al.
CANCER SCIENCE (2004)
The correlation between pretreatment serum hormone levels and treatment outcome for patients with prostatic cancer and bony metastasis
SS Chen et al.
BJU INTERNATIONAL (2002)
Advancing perspectives on prostate cancer: Multihormonal influences in pathogenesis
A Porter et al.
MOLECULAR UROLOGY (2001)
Humoral mechanisms in prostate cancer: A role for FSH
AT Porter et al.
UROLOGIC ONCOLOGY (2001)
Hormonal predictors of prostate cancer: A meta-analysis
T Shaneyfelt et al.
JOURNAL OF CLINICAL ONCOLOGY (2000)
Endocrine status in elderly men with lower urinary tract symptoms: Correlation of age, hormonal status, and lower urinary tract function
G Schatzl et al.
UROLOGY (2000)
Advanced prostate cancer is associated with a decrease in serum luteinizing hormone
H Hilz et al.
EUROPEAN UROLOGY (2000)
Share Paper
